Skip to main content
Home / Leadership / Patrick F. Smith
Certara Patrick Smith

Patrick F. Smith

President, Certara Drug Development Solutions

Dr. Patrick F. Smith is President, Certara Drug Development Solutions, where he leads a global team of drug development scientists that creates value for clients across the entire life cycle and ultimately accelerates patient access to medicines.  With more than 20 years of drug development experience, Patrick has worked across all phases of drug development with deep expertise in infectious diseases, oncology, and inflammation as well as novel early development program design and applying modeling and simulation to solve critical development problems.

Previously, Patrick was co-founder of d3 Medicine (acquired by Certara in 2016), helping to build a healthcare company that specialized in providing strategic support for complex development programs.  Prior to d3 Medicine, Patrick was U.S. Clinical Pharmacology Lead at Roche for more than 5 years, where he worked in various roles of increasing responsibility in clinical pharmacology and translational medicine.  He has served as an Associate Professor at the University at Buffalo School of Pharmacy and Roswell Park Cancer Institute in Buffalo, NY.  Patrick has published more than 125 peer-reviewed articles in journals, including the New England Journal of Medicine and Lancet.  He holds a PharmD from the University of California, San Francisco and completed his clinical residency at Duke University Medical Center.